business

Needham Keeps Buy Rating on Revolution Medicines (RVMD) Despite Wider Loss

Yahoo Finance · May 20, 2026, 7:22 AM · Also reported by 2 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Revolution Medicines to host webcast on phase 3 trial results Investing.com Needham reiterates Aevex stock rating citing strong Q1 results

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Needham Keeps Buy Rating on Revolution Medicines (RVMD) Despite Wider Loss

Also covered by

More in business